Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Podrobná bibliografie
Hlavní autoři:	Shrimanker, R, Pavord, I, Price, R, Bradford, E, Keene, O, Yancey, S
Médium:	Conference item
Vydáno:	American Thoracic Society 2018

Podobné jednotky

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
Autor: Shrimanker, R, a další
Vydáno: (2019)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
Autor: Gunsoy, N, a další
Vydáno: (2017)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Autor: Steven W. Yancey, a další
Vydáno: (2019-09-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Autor: Howell, I, a další
Vydáno: (2024)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Autor: Bel, E, a další
Vydáno: (2014)

Mepolizumab treatment in patients with severe eosinophilic asthma.
Autor: Ortega, H, a další
Vydáno: (2014)

Glucocorticoids and mepolizumab in eosinophilic asthma.
Autor: Bel, E, a další
Vydáno: (2014)

Mepolizumab in refractory eosinophilic asthma.
Autor: Pavord, I, a další
Vydáno: (2010)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Autor: Imran Howell, a další
Vydáno: (2024-07-01)

Mepolizumab for eosinophilic COPD
Autor: Sciurba, F, a další
Vydáno: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
Autor: Price, D, a další
Vydáno: (2019)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
Autor: Yancey, S, a další
Vydáno: (2016)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
Autor: Jiang-Hua Li, a další
Vydáno: (2021-08-01)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
Autor: David B. Price, a další
Vydáno: (2019-08-01)

Mepolizumab, quality of life, and severe eosinophilic asthma.
Autor: Pavord, I
Vydáno: (2017)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Autor: Ortega, H, a další
Vydáno: (2016)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Autor: Shrimanker, R, a další
Vydáno: (2017)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Autor: Haldar, P, a další
Vydáno: (2009)

Biomarkers for severe eosinophilic asthma.
Autor: Yancey, S, a další
Vydáno: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
Autor: Moran, AM, a další
Vydáno: (2020)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
Autor: Ian D. Pavord, a další
Vydáno: (2022-05-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
Autor: Shrimanker, R, a další
Vydáno: (2017)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
Autor: Arian Ghassemian, a další
Vydáno: (2021-01-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
Autor: Shrimanker, R, a další
Vydáno: (2017)

Mepolizumab for eosinophilic chronic obstructive pulmonary disease
Autor: Pavord, I, a další
Vydáno: (2017)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
Autor: Jie Gao, a další
Vydáno: (2018-05-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
Autor: Terufumi Shimoda, a další
Vydáno: (2017-07-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
Autor: Connolly, CM, a další
Vydáno: (2017)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Autor: Pavord, I, a další
Vydáno: (2012)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
Autor: Prazma CM, a další
Vydáno: (2021-06-01)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
Autor: Gao J, a další
Vydáno: (2018-04-01)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
Autor: Menzella F, a další
Vydáno: (2016-06-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
Autor: Pavord, I, a další
Vydáno: (2017)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
Autor: Charlene M. Prazma, a další
Vydáno: (2019-05-01)

Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
Autor: Chio Sakai, a další
Vydáno: (2024-07-01)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
Autor: Berry, M, a další
Vydáno: (2005)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
Autor: Wechsler, M, a další
Vydáno: (2017)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
Autor: Buendía, JA, a další
Vydáno: (2022)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
Autor: Jefferson Antonio Buendía, a další
Vydáno: (2022-06-01)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
Autor: Yuki Hoshino, a další
Vydáno: (2022-04-01)